Ozempic is a medication that helps control blood sugar levels in people with type 2 diabetes. It also treats a heart rhythm disorder called atrial fibrillation (AFib). Sometimes, these two conditions happen together in the same person.
Ozempic works by helping insulin do its job and slowing down how quickly food leaves the stomach. AFib is when the heart beats irregularly or too fast because the upper chambers don’t match the lower chambers. If you have both type 2 diabetes and AFib, you might wonder if it’s safe to take Ozempic.
This is important because there are concerns about how these conditions can affect your heart health.
Ozempic (semaglutide) is a medication used to treat type 2 diabetes. There is no direct evidence of interactions between Ozempic and atrial fibrillation (AFib). However, Ozempic can slow gastric emptying, which may affect the timing of other medications, including anticoagulants often used by AFib patients.
A phase IV clinical study analyzed data from 28,954 people who reported side effects while taking Ozempic.
Among them, 148 people (0.51%) experienced AFib. This suggests a potential link between Ozempic and AFib, particularly in older adults, females, and those with type 2 diabetes.
Healthcare providers recommend monitoring patients with AFib who are prescribed Ozempic. They consider individual risks, lifestyle modifications, and alternative treatments to minimize AFib risks while managing diabetes.
Consulting with a healthcare professional is essential to evaluate the benefits and risks of using Ozempic in patients with AFib.
Ozempic can be used to treat type 2 diabetes and atrial fibrillation (AFib), but there are concerns about its impact on heart health when both conditions coexist.
While there is no direct evidence of interactions between Ozempic and AFib, it may slow gastric emptying, affecting the timing of other medications like anticoagulants.
A study found a potential link between Ozempic use and AFib in older adults, females, and those with type 2 diabetes, but this association is not conclusive.
Healthcare providers recommend monitoring patients with AFib who take Ozempic, considering individual risks, lifestyle modifications, and alternative treatments to minimize AFib risks.
It’s essential to consult with a healthcare professional before starting or stopping Ozempic, especially if you have AFib. They can evaluate the benefits and risks of using Ozempic in your specific situation and provide personalized medical advice.